Clinical Trial Update: Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial examining capecitabine or 5-FU with pegylated interferon alpha-2b for unresectable/metastatic cutaneous squamous cell carcinoma has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma
• Squamous Cell Carcinoma of Skin

Drugs mentioned

• 5-FU (5-fluorouracil)
• Capecitabine (capecitabine)
• Pegylated Interferon Alpha-2b (pegylated interferon alfa-2b)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Squamous Cell Carcinoma of Skin, Carcinoma, Squamous Cell | Phase 2 | Status: COMPLETED | Results posted: 2018-07-20